Paid Clinical Trials Birmingham

Discover 910 paid clinical trials in Birmingham, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 910

Investigational CMV Vaccine Study for Volunteers Ages 9–15Investigational CMV Vaccine Study for Volunteers Ages 9–15

PHASE1

PHASE2

Sponsor:

Moderna

Location:

Birmingham AL, Columbus GA, Atlanta GA, Decatur GAshow 43 more

Code:

NCT05575492

Conditions

Cytomegalovirus

Eligibility Criteria

Sex: All

Age: 9 - 15

Healthy Volunteers: Accepted

Interventions

mRNA-1647

Placebo

Shunt vs. StentComparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)

Recruiting

Sponsor:

Carelon Research

Location:

Birmingham AL, Atlanta GA, Memphis TN, Charlotte NCshow 20 more

Code:

NCT05268094

Conditions

Congenital Heart Disease in Children

Eligibility Criteria

Sex: All

Age: 1 - 30

Healthy Volunteers: Not accepted

Interventions

Ductal Arterial Stent

Systemic-to-Pulmonary Artery Shunt

Clean AirMulti-Center Clean Air Randomized Controlled Trial in COPD

Recruiting

PHASE3

Sponsor:

JHSPH Center for Clinical Trials

Location:

Birmingham AL, Iowa City IA, Ann Arbor MI, Baltimore MDshow 3 more

Code:

NCT06376994

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

Air cleaner

Sham air cleaner

LevocarnitineStudying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma

Recruiting

PHASE3

Sponsor:

Children's Oncology Group

Location:

Birmingham AL, Atlanta GA, Nashville TN, Jackson MSshow 138 more

Code:

NCT05602194

Conditions

B Acute Lymphoblastic Leukemia

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

B Acute Lymphoblastic Leukemia, BCR-ABL1-Like

Lymphoblastic Lymphoma

Mixed Phenotype Acute Leukemia

Eligibility Criteria

Sex: All

Age: 15 - 40

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Calaspargase Pegol

Levocarnitine

Pegaspargase

Quality-of-Life Assessment

BI 1839100A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis

Recruiting

PHASE2

Sponsor:

Boehringer Ingelheim

Location:

Birmingham AL, Gulfport MS, Spartanburg SC, Charleston SCshow 21 more

Code:

NCT06360094

Conditions

Idiopathic Pulmonary Fibrosis

Progressive Pulmonary Fibrosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BI 1839100

Placebo

Relatlimab & NivolumabA Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma

Recruiting

PHASE1

PHASE2

Sponsor:

Bristol-Myers Squibb

Location:

Birmingham AL, Nashville TN, Jackson MS, Saint Louis MOshow 18 more

Code:

NCT05255601

Conditions

Lymphoma, Non-Hodgkin

Hodgkin Disease

Eligibility Criteria

Sex: All

Age: 0 - 30

Healthy Volunteers: Not accepted

Interventions

Relatlimab

Nivolumab

Avonex & ZocorA Safety Study of Combination Treatment With Avonex and Zocor in Relapsing Remitting Multiple Sclerosis

Recruiting

PHASE3

Sponsor:

Alabama Neurology Associates, PC

Location:

Birmingham AL

Code:

NCT00242268

Conditions

Relapsing Remitting Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Simvastatin

CRB-701A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

Recruiting

PHASE1

PHASE2

Sponsor:

Corbus Pharmaceuticals Inc.

Location:

Birmingham AL, Huntersville NC, Orlando FL, Tyler TXshow 11 more

Code:

NCT06265727

Conditions

Solid Tumor, Adult

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CRB-701

CLN-619 & PembrolizumabA Study of CLN-619 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors

Recruiting

PHASE1

Sponsor:

Cullinan Therapeutics Inc.

Location:

Birmingham AL, Nashville TN, Huntersville NC, Sarasota FLshow 8 more

Code:

NCT05117476

Conditions

Advanced Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CLN-619

Pembrolizumab

Nivolumab, Ipilimumab, CabozantinibTesting the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Recruiting

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Birmingham AL, Atlanta GA, Johns Creek GA, Franklin TNshow 368 more

Code:

NCT03866382

Conditions

Bladder Adenocarcinoma

Bladder Clear Cell Adenocarcinoma

Bladder Mixed Adenocarcinoma

Bladder Neuroendocrine Carcinoma

Bladder Small Cell Neuroendocrine Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Bone Scan

Cabozantinib S-malate

Computed Tomography

Echocardiography Test

ObeldesivirStudy of Obeldesivir to Treat Children With Respiratory Syncytial Virus (RSV) Infection

Recruiting

PHASE2

Sponsor:

Gilead Sciences

Location:

Oneonta AL, Union City GA, Macon GA, Lafayette LAshow 30 more

Code:

NCT06784973

Conditions

RSV Infection

Eligibility Criteria

Sex: All

Age: 0 - 5

Healthy Volunteers: Not accepted

Interventions

Obeldesivir

Obeldesivir Placebo